JP2025508343A5 - - Google Patents
Info
- Publication number
- JP2025508343A5 JP2025508343A5 JP2024545274A JP2024545274A JP2025508343A5 JP 2025508343 A5 JP2025508343 A5 JP 2025508343A5 JP 2024545274 A JP2024545274 A JP 2024545274A JP 2024545274 A JP2024545274 A JP 2024545274A JP 2025508343 A5 JP2025508343 A5 JP 2025508343A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210111504 | 2022-01-29 | ||
| CN202210111504.5 | 2022-01-29 | ||
| CN202210985594.0 | 2022-08-17 | ||
| CN202210985594 | 2022-08-17 | ||
| PCT/CN2023/073614 WO2023143537A1 (zh) | 2022-01-29 | 2023-01-28 | Gprc5d抗体及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025508343A JP2025508343A (ja) | 2025-03-26 |
| JPWO2023143537A5 JPWO2023143537A5 (https=) | 2026-02-05 |
| JP2025508343A5 true JP2025508343A5 (https=) | 2026-02-05 |
Family
ID=87470681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545274A Pending JP2025508343A (ja) | 2022-01-29 | 2023-01-28 | Ｇｐｒｃ５ｄ抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250121064A1 (https=) |
| EP (1) | EP4471065A4 (https=) |
| JP (1) | JP2025508343A (https=) |
| KR (1) | KR20240137090A (https=) |
| CN (1) | CN118613507A (https=) |
| WO (1) | WO2023143537A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121752596A (zh) * | 2023-09-13 | 2026-03-27 | 江苏恒瑞医药股份有限公司 | 一种包含特异性结合gprc5d和cd3的双特异性抗体的药物组合物 |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025076127A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025103456A1 (en) * | 2023-11-15 | 2025-05-22 | Nanjing Legend Biotech Co., Ltd. | Gprc5d-binding moieties, chimeric antigen receptors and uses thereof |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| US12545726B1 (en) | 2025-07-22 | 2026-02-10 | Integral Molecular, Inc. | Compositions and methods related to GPRC5D binding agents and variants thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| EP2968144A1 (en) | 2013-03-13 | 2016-01-20 | Mallinckrodt LLC | Liposome oxaliplatin compositions for cancer therapy |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| SI3227339T1 (sl) | 2014-12-05 | 2022-02-28 | Memorial Sloan-Kettering Cancer Center | Himerni antigenski receptorji, ki ciljajo na receptor, povezan z G-proteinom, in njihova uporaba |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| TW201837174A (zh) * | 2017-02-07 | 2018-10-16 | 日商第一三共股份有限公司 | 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子 |
| TWI829667B (zh) * | 2018-02-09 | 2024-01-21 | 瑞士商赫孚孟拉羅股份公司 | 結合gprc5d之抗體 |
| JP2022543551A (ja) * | 2019-07-31 | 2022-10-13 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Ｇｐｒｃ５ｄに結合する抗体 |
-
2023
- 2023-01-28 EP EP23746414.4A patent/EP4471065A4/en active Pending
- 2023-01-28 CN CN202380019068.1A patent/CN118613507A/zh active Pending
- 2023-01-28 JP JP2024545274A patent/JP2025508343A/ja active Pending
- 2023-01-28 KR KR1020247028927A patent/KR20240137090A/ko active Pending
- 2023-01-28 WO PCT/CN2023/073614 patent/WO2023143537A1/zh not_active Ceased
- 2023-01-28 US US18/834,017 patent/US20250121064A1/en active Pending